PSGR has been described to be over-expressed in PCa tissue [13,14] and a multiplexed model based on the detection of PSGR and PCA3 (prostate cancer gene 3) in urine improved the specificity for PCa prediction [15]. The gene discussed is PCA3; the disease is posterior cortical atrophy.